Nurix Therapeutics (NRIX) Shareholder's Equity (2019 - 2026)
Nurix Therapeutics (NRIX) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Nurix Therapeutics |
1.93 Bn |
1.39 Bn |
- |
480.89 Mn |
| Date | Value |
|---|
| Feb 28, 2026 |
480.89 Mn |
| Nov 30, 2025 |
538.75 Mn |
| Aug 31, 2025 |
372.25 Mn |
| May 31, 2025 |
447.60 Mn |
| Feb 28, 2025 |
480.92 Mn |
| Nov 30, 2024 |
526.99 Mn |
| Aug 31, 2024 |
376.86 Mn |
| May 31, 2024 |
370.69 Mn |
| Feb 29, 2024 |
168.75 Mn |
| Nov 30, 2023 |
200.49 Mn |
| Aug 31, 2023 |
233.82 Mn |
| May 31, 2023 |
259.92 Mn |
| Feb 28, 2023 |
274.05 Mn |
| Nov 30, 2022 |
303.70 Mn |
| Aug 31, 2022 |
342.55 Mn |
| May 31, 2022 |
266.74 Mn |
| Feb 28, 2022 |
305.92 Mn |
| Nov 30, 2021 |
342.30 Mn |
| Aug 31, 2021 |
375.22 Mn |
| May 31, 2021 |
398.18 Mn |
